Zentalis Pharmaceuticals Llc (ZNTL) — Cash Flow Quality Index
Latest as of March 2024:
-5.16x
Zentalis Pharmaceuticals Llc (ZNTL) has a Cash Flow Quality Index of -5.16x as of March 2024. Operating cash flow of $-51.97 Million is below net income of $10.07 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how much of Zentalis Pharmaceuticals Llc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-5.16x
Operating CF / Net Income
Operating Cash Flow
$-51.97 Million
USD
Net Income
$10.07 Million
USD
Data as of
Mar 2024
Most recent filing
Annual Cash Flow Quality Index for Zentalis Pharmaceuticals Llc (None–None)
Year-by-year earnings quality comparison for Zentalis Pharmaceuticals Llc. For live market cap and the full company financial profile, see ZNTL stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.